Background/Aims A prospective study identified three patients between 2004 and 2010 with mesectodermal leiomyoma. The study was conducted to analyse the presence or absence of sex steroid hormone receptors in mesectodermal leiomyomas. Methods The clinical features were collated.
Introduction
Intraocular leiomyomas are rare benign smooth-muscle tumours of the uveal tract. [1] [2] [3] In contrast to ocular melanoma, patients with leiomyoma are on average younger and more commonly female. 2 This raises the possibility of hormonal influence on these tumours, 2 and the potential for hormone manipulation therapy. Surgical excision is currently the only available treatment option. We present three consecutive prospective cases of mesectodermal leiomyoma, all of which were immunohistochemically positive for steroid hormone receptors.
Methods
All studies were conducted in accordance with the Declaration of Helsinki. All patients with a histopathological diagnosis of intraocular leiomyoma were prospectively included in the study. Specimens were fixed in standard 10% buffered formalin, processed to paraffin wax, and sections were cut and stained with haematoxylin and eosin. All cases were exposed to immunohistochemistry, with antibodies to smooth-muscle actin and desmin (both 1 : 75 dilution; Dako UK Ltd, Ely, UK), Melan A (1 : 20 dilution; Leica Biosystems, Newcastle, UK), progesterone receptor (PR, 1 : 50 dilution; Vector Labs, Peterborough, UK), oestrogen (ER) receptor, and androgen (AR) receptor (both 1 : 50 dilution; Leica Biosystems). The degree of hormonal receptor positivity was assessed using the scoring system of Leitao et al. 4 Briefly, a 0-3 scale was used to score the slides (score 0: no staining; score 1: 5% of the cells staining or diffuse staining difficult to separate from background; score 2: 6-50% of the cells staining; and score 3: greater than 50% of the cells staining). The scoring was done by one observer (HSM). A result was classed as negative for score 0-1 and positive for score 2-3. 4 Case reports
Case 1
A 60-year-old post-menopausal woman presented with 2 years of intermittent blurring of the right eye. A lesion which was clinically suspicious of a peripheral inferotemporal ciliochoroidal malignant melanoma of the right eye was detected, and she underwent an enucleation (Figures 1a and b) .
Macroscopy showed a white-to-cream ovoid mass, 10 mm in maximum diameter, in the supraciliary space (Figure 2a (Figure 2g ). ER receptors were not expressed (not shown).
Case 2
A 66-year-old post-menopausal woman was referred for routine cataract surgery. She had an incidental finding of a temporal ciliary body lesion in the left eye, well circumscribed on B-scan ultrasound assessment, and its location in the supraciliary region raised the possibility of intraocular leiomyoma (Figure 1c) . She underwent open flap biopsy (Figure 1d ). Histopathology and immunohistochemistry showed a mesectodermal leiomyoma, with positivity for progesterone receptor (Figure 2h ), but negative for both AR and ER receptors (not shown).
The residual lesion has not increased in size and she is doing well following phacoemulsification surgery.
Case 3
A 55-year-old man, initially referral as a glaucoma suspect, was found to have an abnormal amelanotic right temporal iris root. The differential diagnosis was of amelanotic melanoma or leiomyoma. Right eye iridocyclectomy was performed, and the histology and immunohistochemistry were those of mesectodermal leiomyoma with positivity for AR receptor (Figure 2i ), but negative for both progesterone and ER receptor (not shown). Abbreviations: AR, androgen receptor; F, female; M, male; PR, progesterone receptor.
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